2 Stocks that Ark Invest loves for 2021
Let’s take a look at two companies that Wood has her eye on and has recently added to Ark’s large portfolio of funds. 
avatar
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.
2021-02-22 15:05

Investing has always been a world where the masses follow the leaders, whether it is someone like Warren Buffet, who has made billions of dollars off of his value investing strategy, or a visionary like Catherine Wood of Ark Invest. Perhaps no other investing firm is held in higher regard right now as seemingly anything Wood touches turns to investing gold. Part of that is a self-fulfilling prophecy by investors in Ark’s successful investing, or an uncanny ability to understand sectors and companies long before others have even heard of them. As an investor, even if you are just following along with what Ark invests in, you are likely to experience your portfolio grow as everyone else tries to join in on Ark’s success. Let’s take a look at two companies that Wood has her eye on and has recently added to Ark’s large portfolio of funds.

Nano Dimension Ltd. ($9.79|-4.58%): The 3D printing sector has been around for years, but perhaps only recently has it been a popular growth industry for investors to really get involved in. The Israel-based company builds and sells its Dragonfly printers that use Nano Dimension’s patented Lights-out Digital Manufacturing technology that is the only printing platform for electronic circuitry. What does that mean? It means Nano Dimension is able to mass produce things such as circuit boards and semiconductors, which are two crucial components to chip makers. Nano Dimension has been taking advantage of its recent stock price and has held several rounds of direct offerings to raise capital for further research and development. NNDM is planning on applying its printing capabilities to a wide variety of sectors including healthcare, aerospace, defense, research, and automotive and industrial. 

Bionano Genomics, Inc. ($9.73|-1.17%): I have written before about the importance of the genomics industry and how it may shape our healthcare in the future. Apparently Ark is well ahead of us as it has already established a genomics industry ETF called ArkG which has some of the world’s finest genomics and medtech companies in it as holdings. Is Bionano Genomics a part of that fund? Well, no, not yet anyways. Several different Ark investors including Cathie Wood herself have mentioned Bionano as a potential investment in the future, and have raved about its technology and what it can do. Currently ArkG holds Pacific Biosciences of California (NASDAQ:PACB) as its second largest holding, but guess what: Bionano’s Saphyr genome mapping software does things more accurately and cheaper than what PACB can do it for. Genome mapping is at the forefront right now with Bionano getting involved in researching the COVID-19 variants and why some people are more genetically predisposed to seeing milder symptoms. Bionano has already run by over 1,150% over the past 52-weeks, and has graduated from a penny stock to a full-on medtech stock with a $3.6 billion market cap. Investors who want to start a position in BNGO may want to act before Ark does, because once Ark announces it has bought, expect shares of Bionano to shoot through the roof.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Published On
2021-02-22 15:05

avatar
About the Author
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.

$9.73
-$0.12 -1.17%
Perf. YTD 218.31%
52W high -38.02%
52W low 3%
PE Ratio 0
MKT Cap 1.49B
Other:  NNDM

Analyst Ratings
Target Price $10.94
# of Analysts 4
Last updated 2021-03-01


2 Stocks to Buy After Earnings Dips
In an environment where rapid quarter-after-quarter growth is the new expectation, and any sort of regression can cause a well-inflated stock to deflate in a hurry, investors are often provided with a nice buying opportunity off of these market overreactions.
By Mike Sakuraba | 1 week ago

3 Under the Radar Crypto Plays
Let’s take a look at a couple companies that are right in the thick of the Bitcoin industry.
By Mike Sakuraba | 1 week ago

2 Valentine's Day Stocks to Love
Love is probably one industry that will never go out of style and will always be a part of the human experience.
By Mike Sakuraba | 2 weeks ago

2 Cannabis Stocks off to a Hot Start in February
Let’s take a look at a couple of cannabis stocks that are off to a hot start in February.
By Mike Sakuraba | 3 weeks ago

Amazon's big shake up
On Tuesday after the closing bell, Amazon announced its Q4 earnings report which blew the doors off of Wall Street’s expectations.
By Mike Sakuraba | 3 weeks ago

Tesla Disappoints, buy the dip?
In its first quarterly earnings call since becoming a blue-chip stock on the benchmark S&P 500 index, Tesla (NASDAQ:TSLA) disappointed and missed Wall Street estimates nearly across the board.
By Mike Sakuraba | 1 month ago